Should You Buy Alpha Tau Medical Ltd (DRTS) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
DRTS is not a good buy right now for a Beginner long-term investor with $50k–$100k who wants to act immediately. The stock is technically strong in the very near term, but the company still has essentially no revenue (2025/Q3 revenue = 0) and remains loss-making, while options positioning shows heavy put open interest (bearish/defensive sentiment). For your profile, the risk/reward is unfavorable today—do not buy now; wait for clearer fundamental traction or a materially better entry.
Technical Analysis
Price/Trend: The trend is currently bullish short-to-long term (SMA_5 > SMA_20 > SMA_200), and MACD histogram is positive and expanding (0.0154), which supports continued upside momentum.
Momentum: RSI_6 is 68.5, approaching overbought territory—this often means upside can continue, but the margin for error is smaller and pullbacks become more likely.
Levels: Pivot 7.095. Immediate resistance is R1 7.729 (very close to the post-market area ~7.65), then R2 8.121. Support is S1 6.461.
Interpretation: Technically constructive, but the stock is pressing into nearby resistance with elevated momentum; risk of a near-term stall/pullback is non-trivial.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Model-based near-term tendency (pattern analogs): +0.62% next day (70% chance), -0.21% next week, -4.6% next month—this leans against chasing for a long-term entry today.